Chinese scientists discover gene associated with prostate cancer
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target
Beijing: Chinese scientists have identified a new gene strongly associated with prostate cancer, offering new methods for diagnosis and treatment of the disease. The newly identified biomarker, PCSEAT, was discovered by scientists from Suzhou Institute of Biomedical Engineering and Technology, state-run Xinhua news agency reported.
The research reveals that PCSEAT is overexpressed in prostate cancer patients, indicating that PCSEAT may be a potential therapeutic target. The research was published in the journal Biochemical and Biophysical Research Communications in May.
Based on the research, they have developed an early diagnosis for prostate cancer and applied for a patent. The application can significantly improve the accuracy of prostate cancer diagnosis and reduce the cost of diagnosis and treatment. China has seen increasing cases of prostate cancer in recent years.
- India is at par with China in space race: Isro’s K. Sivan
- Measuring all the light there is to see, or not
- Now, you can lace new Nike Adapt BB shoes with your smartphone
- Court asks govt to retest samples of Ghaziabad-based firm’s polio vaccine
- Scientists develop data framework for early detection of Alzheimer’s disease
Editor's Picks »
- What to expect from Q3 results of IndiGo, SpiceJet, Jet Airways
- Forget privatisation, govt has hugged its banks tighter
- Flat profit, rising debt are growing worries for Reliance
- Q3 results: HUL growth off a high base shows it’s on a roll
- DCB Bank Q3 results: Small loans give big pain as farm, mortgages lift delinquencies